Tata Medical And Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 500.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 400.00 Cr
as on 16-11-2024
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 70.00 Cr
as on 16-11-2024
- Revenue -77.89%
(FY 2023)
- Profit -16.05%
(FY 2023)
- Ebitda -92.71%
(FY 2023)
- Net Worth -15.69%
(FY 2023)
- Total Assets -23.23%
(FY 2023)
About Tata Medical And Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 500.00 Cr and a paid-up capital of Rs 400.00 Cr.
The company currently has active open charges totaling ₹70.00 Cr.
The Key Managerial Personnel (KMP) at Tata Medical And Diagnostics Limited India are Girish Krishnamurthy as CEO and Kausik Biswas as Company Secretary. Girish Krishnamurthy, Terri Bresenham, Kanwar Jamwal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33100MH2020PLC342509
- Company No.
342509
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
23 Jul 2020
- Date of AGM
29 Aug 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Tata Medical And Diagnostics?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Girish Krishnamurthy  | Managing Director | 23-Jul-2020 | Current |
| Kausik Biswas | Company Secretary | 23-Mar-2021 | Current |
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Banmali Agrawala | Director | 23-Jul-2020 | Current |
Terri Bresenham  | Director | 23-Mar-2021 | Current |
| Kanwar Jamwal | Director | 01-Dec-2020 | Current |
| Roopa Purushothaman | Director | 05-Oct-2020 | Current |
Financial Performance of Tata Medical And Diagnostics.
Tata Medical And Diagnostics Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 77.89% decrease. The company also saw a substantial fall in profitability, with a 16.05% decrease in profit. The company's net worth observed a substantial decline by a decrease of 15.69%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tata Medical And Diagnostics?
In 2023, Tata Medical And Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹70.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 70.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2022 | Others | ₹70.00 Cr | Open |
How Many Employees Work at Tata Medical And Diagnostics?
Tata Medical And Diagnostics has a workforce of 111 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tata Medical And Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tata Medical And Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
